- English
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
New Products
Sinae intermedia Factory
Sandoo anno 2009 stabilivit, copiam facultatis a R&D gubernatore ad scalam mercatoriam formavimus., inter API, anti-cancer, intermedia medicamenta antiviralia, oeconomiae subtilia, cibaria additiva, necnon clavis media mixtorum polypeptidorum in facie biopharmaceuticorum in mundus.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
- View as
![N-methyl-N-((3R,4R) -4-methylpiperidin-3-yl) -7H-pyrrolo[2,3-d] pyrimidin-4-amine](/upload/6698/n-methyl-n-3r-4r-4-methylpiperidin-3-yl-7h-pyrrolo-2-3-d-pyrimidin-4-amine_906419.gif "N-methyl-N-((3R,4R) -4-methylpiperidin-3-yl) -7H-pyrrolo[2,3-d] pyrimidin-4-amine")
N-methyl-N-((3R,4R) -4-methylpiperidin-3-yl) -7H-pyrrolo[2,3-d] pyrimidin-4-amine
Product Name:N.
Formulae hypotheticae: C13H19N5
Molecular pondus:245.32
CAS Registry Number: 477600-74-1
Acidum Morpholineaceticum 4-
Product Name: 4-Acidi Morpholineacetic
Formulae hypotheticae: C6H11NO3
Molecular pondus:145.16
CAS Registry Number: 3235-69-6
![Acidum carbaMicum, [(1S) -3-Methyl-1-(2-Methylpropyl)-2-oxo-3-butenyl]-, 1,1-diMethylethyl niensis (9CI)](/upload/6698/carbamic-acid-1s-3-methyl-1-2-methylpropyl-2-oxo-3-butenyl-1-1-dimethylethyl-ester-9ci-_129214.gif "Acidum carbaMicum, [(1S) -3-Methyl-1-(2-Methylpropyl)-2-oxo-3-butenyl]-, 1,1-diMethylethyl niensis (9CI)")
Acidum carbaMicum, [(1S) -3-Methyl-1-(2-Methylpropyl)-2-oxo-3-butenyl]-, 1,1-diMethylethyl niensis (9CI)
Product Name: CarbaMic acid, [(1S)-3-Methyl-1-(2-Methylpropyl)-2-oxo-3-butenyl]-, 1,1-diMethylethyl ester (9CI)
Formulae hypotheticae: C14H25NO3
Molecular pondus:255.35
CAS Subcriptio Number:247068-81-1
![CarbaMic acid, N-[(1S)-3-Methyl-1-[[[(2R)-2-Methyl-2-oxiranyl]carbonyl]butyl]-, 1,1-diMethylethyl ester](/upload/6698/carbamic-acid-n-1s-3-methyl-1-2r-2-methyl-2-oxiranyl-carbonyl-butyl-1-1-dimethylethyl-ester_70245.gif "CarbaMic acid, N-[(1S)-3-Methyl-1-[[[(2R)-2-Methyl-2-oxiranyl]carbonyl]butyl]-, 1,1-diMethylethyl ester")
CarbaMic acid, N-[(1S)-3-Methyl-1-[[[(2R)-2-Methyl-2-oxiranyl]carbonyl]butyl]-, 1,1-diMethylethyl ester
Product Name: CarbaMic acid, N-[(1S)-3-Methyl-1-[[[(2R)-2-Methyl-2-oxiranyl]carbonyl]butyl]-, 1,1-diMethylethyl ester
Formulae hypotheticae: C14H25NO4
Molecular Weight:271.35
CAS Subcriptio Number:247068-82-2
-2-Amino-4-methyl-1-((2R)-2-methyloxiranyl) -1-pentanone trifluoroacetate
Product Name:(2S)-2-Amino-4-methyl-1-((2R)-2-methyloxiranyl)-1-pentanone trifluoroacetate
Formulae hypotheticae: C9H17NO2.C2HF3O2
Molecular pondus:285.26
CAS Subcriptio Number:247068-85-5
![N-[(S)-2-(tert-Butoxycarbonylamino)-4-phenylbutanoyl]-L-leucyl-L-phenylalanine methyl ester](/upload/6698/n-s-2-tert-butoxycarbonylamino-4-phenylbutanoyl-l-leucyl-l-phenylalanine-methyl-ester_229416.gif "N-[(S)-2-(tert-Butoxycarbonylamino)-4-phenylbutanoyl]-L-leucyl-L-phenylalanine methyl ester")
N-[(S)-2-(tert-Butoxycarbonylamino)-4-phenylbutanoyl]-L-leucyl-L-phenylalanine methyl ester
Product Name:N.
Formulae hypotheticae: C31H43N3O6
Molecular pondus:553.7
CAS Registry Number: 868539-96-2
Sandoo magnus intermedia fabrica et praebitus in Sinis est. Officina nostra in intermedia exportare et importare plus quam 10 annos posita est, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniarum Regnum, Franciae, etc., paulatim plus quam XX operiunt. terris per orbem.
